Robert C. Pordy

3 Patents

• US126066382026

  Dosing Regimens for Use with PCSK9 Inhibitors

  REGENERON PHARAMACEUTICALS, Inc.

  0 cites
• US120297882024

  Methods for Increasing Lean Body Mass with an Exercise Regimen and a GDF8 Inhibitor That Is an Anti-gdf8 Antibody

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US119040172024

  Methods for Reducing or Eliminating the Need for Lipoprotein Apheresis in Patients with Hyperlipidemia by Administering Alirocumab

  REGENERON PHARMACEUTICALS, Inc.

  0 cites